Work

HTA87 Caplacizumab for the Treatment of Acquired Thrombotic Thrombocytopenic Purpura (ATTP): Technology Qualification in Colombia

Year: 2023

Type: conference-abstract

Source: Value in Health

DOI: 10.1016/j.jval.2023.03.2653

Authors: J. Soto, L.M. Gomez, P. Lasalvia, C. Castellanos, C. Casallas, S. Londono

Language: English

Topic: Complement system in diseases

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4380149022

Cites:

Cited by:

Related to: 10